References
Fujitani K, Yang H-K, Mizusawa J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial. Lancet Oncol. 2016;17:309–18.
Nie R, Yuan S, Li Y et al. Risk-stratification model to select conversion surgery for advanced gastric cancer patients. Chin J Cancer Res. 2019;31:178–87.
Fukuchi M, Ishiguro T, Ogata K et al. Prognostic role of conversion surgery for unresectable gastric cancer. Ann Surg Oncol. 2015;22:3618–24.
Chen G, Yuan S, Nie R et al. Surgical outcome and long-term survival of conversion surgery for advanced gastric cancer. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08559-7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, GM., Nie, RC. & Chen, YB. ASO Author Reflection: Tending Towards a Personalized Treatment for Advanced Gastric Cancer Patients by Adding the Conversion Surgery. Ann Surg Oncol 27, 4261–4262 (2020). https://doi.org/10.1245/s10434-020-08599-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08599-z